Principles of Coagulation Screening II

Slides:



Advertisements
Similar presentations
Basic coagulation techniques and Quality control issues
Advertisements

University of North Carolina-Chapel Hill Division of Hematology
Coagulation Bruno Sopko.
Pre-analytical factors that can affect coag test results
Initiation substances activate s by proteolysis a cascade of circulating precursor proteins which leads to the generation of thrombin which in turn converts.
Quantitative Fibrinogen Mr. Mohammed A. Jaber.  Fibrinogen assays are quantitative techniques to measure the amount of functional fibrinogen present.
Dr msaiem Acquired Coagulation Disorders Dr Mohammed Saiem Al-dahr KAAU Faculty of Applied Medical Sciences.
Week 6: Secondary Hemostasis Plasmatic factors Plasmatic factors Intrinsic pathway Intrinsic pathway Extrinsic pathway Extrinsic pathway Specimen Specimen.
MLAB 1227: C OAGULATION K ERI B ROPHY - M ARTINEZ Secondary Hemostasis Part Three.
One Stage Factor V Assay
Coagulation Time of whole blood
Tests to measure fibrin clot Lecture 9: General Approach in Investigation of Haemostasis.
MLAB Coagulation Keri Brophy-Martinez
General Approach of Haemostasis
Secondary Hemostasis Part One MLAB Coagulation Keri Brophy-Martinez.
©2007 Wortham Laboratories, Inc.
Approach to Bleeding Disorders
APPROACH TO BLEEDING DISORDERS. History of Bleeding Spontaneous vs. trauma/surgery-induced Ecchymoses without known trauma Medications or nutritional.
MIXING STUDIES General Approach of Haemostasis
Disseminated Intravascular Coagulation. XIIa Coagulation cascade IIa Intrinsic system (surface contact ) XII XI XIa Tissue factor IX IXa VIIa VII VIIIVIIIa.
  The prothrombin time is therefore the time required for the plasma to clot after an excess of thromboplastin and an optimal concentration of calcium.
SCREENING COAGULATION STUDIES When & when NOT to do them.
In this exercise, two tests will be performed to screen for defective clotting factors. The formation of thrombin in the plasma samples will be inhibited.
Dr. S. Parthasarathy MD DA DNB PhD (physio) Mahatma Gandhi medical college and research institute, puducherry – India Prothrombin time.
APTT. Causes of prolonged aPTTs: 1.Spurious (common to many Coag tests): – dilution (saline, Tx), underfilled specimen, clotted, prolonged tourniquet.
Tests to Measure Fibrin formation Mr. Mohammed A. Jaber.
Investigation of Haemostasis MS. c. program Lab-9.
Activated Partial Thromboplastin Time (aPTT)
HEMOSTASIS When blood vessels are cut or damaged, the loss of blood from the system must be stopped before shock and possible death occur. This is accomplished.
Laboratory Testing in Coagulation Coagulation Keri Brophy-Martinez.
Factor Assays Robert Gosselin MT (ASCP), CLS.
Intrinsic pathway Extrinsic pathway Common pathway The extrinsic pathway was required the addition of an exogenous trigger (originally provided by tissue.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
University of North Carolina-Chapel Hill Division of Hematology
Chapter 17 Coagulation Testing
Chapter 23. Bleeding disorders associated with coagulopathy
Bleeding Tendency Dr. Mervat Khorshied Ass. Prof. of Clinical and Chemical Pathology.
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
Approach to the Patients with Bleeding Tendency Hwi-Joong Yoon, MD Department of Hematology/Oncology Kyung Hee University School of Medicine.
HEMOSTASIS A.C.KAROBIA. HEMOSTASIS-definition Arrest of bleeding by: -Normal vasoconstriction -Abnormal obstruction -Coagulation or surgical means.
Obada Al-Eisa Saud Bashtawy Emad Mansour.  It is an acquired condition characterized by massive activation of the coagulation system.  It is always.
Coagulation ICU – RLH Mike Cunningham 11 th December 2008.
One-Stage Quantitative
Approach To Bleeding Disorders In Neonates
MLAB Coagulation Keri Brophy-Martinez
Pre-analytical factors that can affect coag test results
Chapter 18 Disorders of Hemostasis
These factors prevent blood clotting - in normal state.
Biochemistry of Coagulation
One Stage Factor V Assay
Haematology.
General Approach of Haemostasis
General Principles of Hemostasis Kristine Krafts, M.D.
General Approach in Investigation of Hemostasis
University of North Carolina-Chapel Hill Division of Hematology
Mixing Studies-aPTT or PT 1:1 Mix
and anti-thrombotic pharmocology Tom Williams
Steps in clotting mechanism
Activated Partial Thromboplastin Time (aPTT)
How to Interpret and Pursue an Abnormal Prothrombin Time, Activated Partial Thromboplastin Time, and Bleeding Time in Adults  Arif H. Kamal, MD, Ayalew.
Intrinsic pathway Formation of prothombin activator is the central event in the clotting pathway For its formation the pathway that is initiated by.
Coagulation Factor Assays
Tests to measure fibrin clot
General Principles of Hemostasis Kristine Krafts, M.D.
HAEMOPHILIA TREATMENT CENTRE
Tests to measure fibrin clot
Tests to measure fibrin clot
Hemostasis and Coagulation
Presentation transcript:

Principles of Coagulation Screening II MLS 524

Prothrombin Time (PT) The PT measures the integrity of the "extrinsic" and "common" pathways (factors VII, V, X, prothrombin, and fibrinogen). It measures the time necessary to generate fibrin after activation of factor VII. As with the interpretation of a prolonged APTT, a prolonged PT may reflect either factor deficiency or the presence of a circulating inhibitor of coagulation.

Prothrombin Time (PT)(contd.) The distinction is made by repeating the test after a 1:1 mix with normal plasma. The test is more sensitive than the APTT for deficient levels of factors, and a relatively small drop in factor VII levels may prolong the PT. Principle Citrated plasma and an activating agent (usually thromboplastin extracted from animal brain) are incubated at 37°C.

Prothrombin Time (PT)(contd.) The plasma is recalcified and the time is measured until fibrin filaments are observed. Each laboratory has its own normal value, usually between 12 and 15 seconds. Clinical Significance Inherited deficiency of factor VII is a rare bleeding disorder characterized by a prolonged PT and a normal APTT. The PT completely corrects when mixed with normal plasma.

Prothrombin Time (PT)(contd.) Acquired deficiencies are usually related to liver disease, warfarin therapy, or depletion secondary to consumptive coagulopathy, severe bleeding, or massive transfusion. Circulating inhibitors are most often directed at factor X or thrombin. Most common is heparin or products of fibrinolysis.

Thrombin Time This test measures the time necessary to drive the reaction of fibrinogen to fibrin in the presence of thrombin. It measures the integrity of the previous reactions and isolates an abnormality to either a decrease in normal fibrinogen or an inhibitor to its activation. Abnormalities can be explained in one of three ways: deficient fibrinogen (< 100 mg/dl), abnormal fibrinogen, an inhibitor to the reaction.

Thrombin Time(contd.) As with other tests of the coagulation cascade, if a 1:1 mixing study normalizes the prolonged time, one is dealing with factor deficiency. As it pertains to fibrinogen, however, one must distinguish a decrease in normal fibrinogen from the production of an abnormal fibrinogen (dysfibrinogenemia).

Thrombin Time(contd.) Method Citrated plasma is incubated at 37°C and thrombin is added to the solution. Time is measured from the addition of thrombin to the generation of fibrin filaments. Calcium is unnecessary.

Thrombin Time(contd.) Clinical Significance Acquired deficiency of fibrinogen is usually due to a consumptive coagulopathy or, less often, severe liver disease. Hereditary deficiencies exist, but with variable clinical presentations. Afibrinogenemia is an often fatal childhood condition.

Thrombin Time(contd.) Abnormal fibrinogen (dysfibrinogenemia) can be acquired or inherited. The acquired form is usually found in association with severe liver disease, but has been reported in other diseases. The congenital form is rare, usually autosomal dominant. The most common acquired inhibitors of this reaction are heparin and fibrin degradation products (FDP).

Factor Assays One stage PT based assay – to establish the levels of factors V, VII, X and II (prothrombin). It is a method based on prothrombin time used. The assay of a clotting factor relies upon measuring the degree of correction of the PT when plasma is added to a plasma sample specifically deficient in the factor to be measured. Materials such as Reference/standard plasma (with known concerntration 100%/100iu/dl),patient’s plasma ,pt reagent(thromboplastin),CaCl2 and buffered saline. Reference range for FVII is 50-150iu/dl;

Factor Assay One stage APTT based assay – to establish the levels of factors VIII, IX and XI It assesses the interaction of a large number of coagulation factors. Reference range is 50-150iu/dl and 65-125iu/dl for FXI Chromogenic Assay for FXIII Fibrinogen assay by Clauss Technique Diluted plasma is clotted with a strong thrombin solution. Other fibrionogen assay methods includes, immunological,nephelometric techniques and the use of automated analysers.